Cutler Group LP Takeda Pharmaceutical CO LTD Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$12.42 - $15.62 $3,726 - $4,686	300 Added 15.43%	2,244 $35,000
Q3 2022 Oct 25, 2022	BUY	$12.8 - $28.65 $24,883 - $55,695	1,944 New	1,944 $25,000
Q1 2022 Apr 14, 2022	BUY	$13.54 - $15.35 $40,620 - $46,050	3,000 Added 1500.0%	3,200 $45,000
Q4 2021 Jan 18, 2022	SELL	$13.17 - $16.4 $2,765 - $3,443	-210 Reduced 51.22%	200 $2,000
Q3 2021 Oct 26, 2021	SELL	$16.3 - $17.26 $30,970 - $32,794	-1,900 Reduced 82.25%	410 $6,000
Q2 2021 Jul 19, 2021	BUY	$16.55 - $18.64 $38,230 - $43,058	2,310 New	2,310 $38,000
Q1 2021 Apr 26, 2021	SELL	$16.71 - $19.9 $16,710 - $19,900	-1,000 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$13.02 - $20.31 $95,072 - $148,303	-7,302 Reduced 87.95%	1,000 $15,000
Q4 2019 Feb 06, 2020	SELL	$16.88 - $20.83 $40,512 - $49,991	-2,400 Reduced 22.43%	8,302 $163,000
Q3 2019 Oct 28, 2019	SELL	$16.15 - $17.99 $179,087 - $199,491	-11,089 Reduced 50.89%	10,702 $184,000
Q2 2019 Aug 09, 2019	BUY	$16.58 - $20.49 $361,294 - $446,497	21,791 New	21,791 $385,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.